Clinical trial Recruiting at 1 site Interventional Ages 20 and up

Grocery labels for products with non-sugar sweeteners in Brazil

Official title: Effects of a Non-sugar Sweetener Label on Parents' Selection of Foods and Beverages in Brazil: a Randomized Clinical Trial.

Run by George Washington University · NCT07249008 · Data updated 2026-11-12

This test will see if different front-of-package warning labels about non-sugar sweeteners change what Brazilian parents pick for their 2–12 year-old children's yogurts, drinks, granola and cereal bars.

More Control Group trials

Quick facts

Study typeInterventional
Ages20 Years and up
SexAll
Enrollment1068 (estimated)
SponsorGeorge Washington University
Academic / other
Locations1 site (Washington D.C., District of Columbia)
StatusRecruiting
StartedFebruary 15, 2026
Main results expectedJune 30, 2026
Study endsJune 30, 2026
Registry record updatedApril 15, 2026
Trial IDNCT07249008 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 20 or older who live in Brazil, are parents or guardians of a 2–12 year-old child, are primarily responsible for grocery shopping, and can read Portuguese.

Probably not a fit

People who are under 20, not parents/guardians of a 2–12 year-old, not the primary grocery shopper, unable to read Portuguese, or who do not live in Brazil would not be eligible and would not benefit from participating.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This online randomized experiment enrolls Brazilian parents who do most of the household grocery shopping and asks them to choose one yogurt, three beverages (for breakfast, lunch, and dinner), one granola and one cereal bar for their child. Participants are randomly assigned to one of three arms: no non-sugar sweetener (NSS) label (control), a NSS warning label modeled on Mexico's label, or the magnifying-glass NSS label used in Brazil. Recruitment uses a nationwide online panel with quotas for education, race and geography to approximate the national profile. The primary outcome is how label exposure changes product selections for children aged 2–12.

Why it matters

Potential benefit: If successful, the results could inform labeling policies that help parents choose fewer products with non-sugar sweeteners for their children and improve dietary choices.

How similar studies have gone: Other front-of-package labeling studies (for sugar, salt and calories) have changed consumer choices and purchases, but applying NSS-specific warnings is relatively new and less extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Eligible participants include:

* Adults aged 20 years or older,
* Living in Brazil
* Parents or guardians of children between 2 and 12 years old
* Primarily responsible for the household grocery shopping (more than 50%)
* Can read and understand Portuguese

Recruitment will occur nationwide through an online panel, with quotas for education, race, and geographic distribution to approximate the national profile.

Individuals will be excluded if

* Not a parent or guardian of a child aged 2-12 years
* Younger than 20 years
* Not primarily responsible for more than half of the household grocery shopping
* Unable to read or understand Portuguese
* Do not provide informed consent.

Where it's running

  • Milken Institute School of Public Health
    Washington D.C., District of Columbia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.